Mark E. Jones
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria 17
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 12
- Epidemiology top 1%
- Pneumonia and Respiratory Infections 28
- Pharmacology top 1%
- Antibiotics Pharmacokinetics and Efficacy 23
-
- Antimicrobial Resistance in Staphylococcus 25
-
- Streptococcal Infections and Treatments 10
-
- Bacterial Infections and Vaccines 6
-
- Pharmaceutical Practices and Patient Outcomes 5
- Co-authors
- Daniel F. SahmClyde ThornsberryJames A. KarlowskyIan A. CritchleyLaurie J. KellyDeborah C. DraghiAlan T. EvangelistaFranz‐Josef Schmitz
- Journals
- Antimicrobial Agents and Chemotherapy (17 papers)Clinical Infectious Diseases (5 papers)International Journal of Antimicrobial Agents (5 papers)
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Mark E. Jones
70 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 136
- Molecular Medicine 985
- Applied Microbiology and Biotechnology 308
- Clinical Biochemistry 517
- Epidemiology 1.8k
- Pharmacology 882
Countries citing papers authored by Mark E. Jones
This map shows the geographic impact of Mark E. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Jones more than expected).
Fields of papers citing papers by Mark E. Jones
This network shows the impact of papers produced by Mark E. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Jones. The network helps show where Mark E. Jones may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark E. Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2023 | 22 | |
| 3 | 2023 | 0 | |
| 4 | 2018 | 20 | |
| 5 | 2017 | 95 | |
| 6 | 2007 | 43 | |
| 7 | 2005 | 47 | |
| 8 | 2004 | 211 | |
| 9 | 2003 | 34 | |
| 10 | 2003 | 68 | |
| 11 | 2003 | 1 | |
| 12 | 2003 | 172 | |
| 13 | 2002 | 18 | |
| 14 | 2002 | 18 | |
| 15 | 2002 | 173 | |
| 16 | 2002 | 13 | |
| 17 | 2001 | 9 | |
| 18 | 1999 | 2 | |
| 19 | 1999 | 10 | |
| 20 | 1997 | 47 |
About Mark E. Jones
Mark E. Jones is a scholar working on Molecular Medicine, Clinical Biochemistry, Infectious Diseases, Pharmacology and Geriatrics and Gerontology, having authored 73 papers that have together received 3.2k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (28 papers), Antimicrobial Resistance in Staphylococcus (25 papers), Antibiotics Pharmacokinetics and Efficacy (23 papers), Antibiotic Resistance in Bacteria (17 papers), Bacterial Identification and Susceptibility Testing (12 papers), Streptococcal Infections and Treatments (10 papers), Bacterial Infections and Vaccines (6 papers) and Pharmaceutical Practices and Patient Outcomes (5 papers). The work is most often cited by research in Molecular Medicine (985 citations), Applied Microbiology and Biotechnology (308 citations), Clinical Biochemistry (517 citations), Epidemiology (1.8k citations) and Pharmacology (882 citations). Mark E. Jones has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Daniel F. Sahm, Clyde Thornsberry, James A. Karlowsky, Ian A. Critchley, Laurie J. Kelly, Deborah C. Draghi, Alan T. Evangelista, Franz‐Josef Schmitz, James B. Kahn and Yolanda Mauriz. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, International Journal of Antimicrobial Agents, Diagnostic Microbiology and Infectious Disease and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.